Tidepool (company)

Tidepool
TypeNon-profit
IndustryHealthcare software, diabetes management
Founded2013 (2013) in San Francisco, California
HeadquartersSan Francisco, California, United States
ProductsTidepool Web, Tidepool Mobile, Tidepool Loop
Websitewww.tidepool.org

Tidepool is a non-profit software organisation founded in 2013 in San Francisco, California, which develops open-source tools to help people manage diabetes. Its work spans data visualisation platforms for diabetes device data and, most notably, Tidepool Loop, an open-source automated insulin delivery (AID) system. The organisation works with device manufacturers including Medtronic and Dexcom to support interoperability across insulin pumps and continuous glucose monitors.[1]

Products

Tidepool's core products include:

  • Tidepool Web — a data visualisation platform that aggregates data from a wide range of diabetes devices, including insulin pumps, continuous glucose monitors and blood glucose meters, allowing users and clinicians to review trends over time.
  • Tidepool Mobile — a companion mobile application for logging meals, exercise and other contextual information alongside device data.
  • Tidepool Loop — an open-source automated insulin delivery system that links a compatible continuous glucose monitor with an insulin pump to automate basal insulin dosing based on glucose readings. Tidepool Loop received FDA 510(k) clearance, making it the first FDA-cleared open-source AID application.[2]

Interoperability

A central objective of Tidepool's work is promoting interoperability among diabetes devices, enabling patients to mix and match components from different manufacturers rather than being locked into proprietary closed-loop systems. The organisation collaborated with Medtronic on an interoperable automated insulin pump approach.[3]

References

  1. ↑ Best, Jo. "These open-source software developers want to give diabetics new tools to manage their condition". ZDNet.
  2. ↑ Downey, Laura; O'Donnell, Shane; Melvin, Tom; Quigley, Muireann (24 October 2023). "A European regulatory pathway for Tidepool loop following clearance in the United States?". Diabetic Medicine. 41 (4) e15246. doi:10.1111/dme.15246. PMID 37873612.
  3. ↑ "Tidepool CEO talks Pre-Cert era, interoperability". MedTech Dive.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.